A biometrical study of the relationship between sodium-lithium countertransport and triglycerides

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66400/1/j.1469-1809.1997.6120121.x.pd

Heterogeneity of the blood pressure distribution among Solomon Islands societies with increasing acculturation

This study illustrates the very complex nature of gene by environmental interactions influencing the blood pressure (BP) distribution in a series of genetically distinctive populations undergoing rapid acculturation. We report the results of two BP and anthropometric surveys on Solomon Islands societies separated by an interval of 14 to 19 years. While differences in acculturation existed at the time of the initial survey, the interval between surveys was marked by rapid acculturation in almost all societies. Seven of the eight societies originally covered were included in the resurvey, and a large but variable proportion of the original sample subjects was recovered in the follow-up. Because the genetic relationships of the societies have been described, we were able to establish the following points concerning the role of genetic differences in determining the distribution of BP among these populations and, more important, the interaction of these genetic differences with changes associated with increasing acculturation: 1) In the initial survey, mean adjusted systolic and diastolic BPs were significantly heterogeneous among societies within and among genetically related clusters of societies (genetic clusters) and sexes. At the same time, rank differences in these means were not associated with rank differences in acculturation status among societies ignoring cluster membership. 2) Importantly, in the follow-up survey increasing acculturation resulted in the disappearance of significant differences in mean systolic and diastolic BP among genetic clusters in males , despite continued significant heterogeneity among societies within genetic clusters. In females, differences among genetic clusters persisted, but the degree of significance was substantially less with increasing acculturation. We interpret these changes as evidence for genotype by environment interaction. 3) There were significant differences in interindividual variances of both systolic and diastolic BPs among genetic clusters in the first survey. Ranks of these variances were not significantly associated with acculturation rank. In the follow-up survey, however, most societies showed striking increases in the variance of both systolic and diastolic BPs with increased acculturation. These increases in variance of both systolic and diastolic BPs may be related to a) shifts in demography and/or anthropometry of some societies; b) increased range and intensity of environmental factors affecting BP and associated with increased acculturation; and/or c) genotype by environmental interactions. 4) The correlation between systolic and diastolic BP decreased over the interval for all societies within and among genetic clusters. This trend was partly the result of larger changes in variances for systolic than diastolic BP in the resurveys. This study illustrates the enormous heterogeneity in the BP distribution that can occur even among populations with relatively similar ethnic and cultural backgrounds.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/37648/1/1330810406_ftp.pd

Complex adaptive systems and human health: the influence of common genotypes of the apolipoprotein E ( ApoE ) gene polymorphism and age on the relational order within a field of lipid metabolism traits

We analyzed the influence of age, apolipoprotein E ( ApoE ) genotype, and their interaction on the variation of each of all possible pairwise correlations among plasma levels of ApoE, ApoB, total cholesterol, triglyceride, and HDL cholesterol. Our cross-sectional study sample included 1,876 individuals (979 females and 897 males) from the Rochester, MN population, unselected for health, with a common ApoE genotype of ε 32 , ε 33 , or ε 43 , and ranging in age from 5 to 90 years. We conducted analyses on data from female and male subjects separately, using a hierarchical set of generalized additive models. The age changes in the correlations were estimated using a 30-year sliding window across the age range. There were qualitative differences between genders in the age at which the peaks in the correlations occurred. For female subjects, peaks in correlations were mostly in the middle and older age windows, whereas in males, peaks were mostly in the younger and middle age windows. We found for both genders that for each of the possible pairwise correlations, the influence of age was significantly dependent on ApoE genotype (all Pr <0.0001). We also found for female and male subjects that the ε 32 - and ε 43 - specific age changes in the correlations were each significantly different from those for the ε 33 genotype ( Pr <0.0001), with two exceptions for males (marginally significant differences, P <0.08). We conclude that the influence of ApoE genotypic variation extends far beyond the levels of the gene product, to the dynamics of the relational order among measures of lipid metabolism with age. Moreover, age and common ApoE genotype are not independent predictors of the gender-specific changes in relational order that we observed among these measures of lipid metabolism. These results have implications for the development and application of therapeutic approaches to treat human disease and our enhanced understanding of the role of genetic variation in the dynamic actions of complex adaptive systems with age that occur in response to environmental change. These dynamic actions emerge as the phenotypes that are measures of human health in the population at large.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/42267/1/439-107-5-466_s004390000394.pd

Genetic structure of five susceptibility gene regions for coronary artery disease: disequilibria within and among regions

We analyzed two-locus disequilibria for 16 polymorphic loci of seven susceptibility genes for coronary artery disease located in five chromosomal regions distributed across four chromosomes. Included were the genes coding for apolipoprotein B ( ApoB , chromosome 2, four marker loci), lipoprotein lipase ( LPL , chromosome 8, three marker loci), apolipoproteins AI, CIII, AIV ( ApoAI–CIII–AIV , chromosome 11, three marker loci), apolipoprotein E ( ApoE , chromosome 19, two marker loci), and the low density lipoprotein receptor ( LDLR , chromosome 19, four marker loci). Our sample included 540 unrelated individuals from the Rochester, Minn. population. There were no statistically significant deviations of single-locus genotypes from Hardy-Weinberg equilibrium. The strongest associations within genes were for composite diallelic disequilibria; 17/19 were significant (13 at Pr <0.001, 1 at Pr <0.01, 3 at Pr <0.05). These observations suggest marker alleles within genes have a shared evolutionary history reflected by disequilibria that have not been dissipated by recombination. Disequilibrium was not generally concordant with the physical orderings of markers. Only two significant higher-order disequilibria were observed although 12 triallelic disequilibria were at maximum possible values. We observed 19 statistically significant disequilibria ( Pr <0.05; 4 composite diallelic, 13 triallelic, and 2 quadriallelic) between 101 pairs of marker loci, where each locus in a pair was from a different unlinked region. These unexpected results are most likely explained by recent historical factors, including worldwide population expansion and amalgamation with continuous admixture, that influence the genetic structure (organization of alleles and non-alleles into genotypes) of a population. We conclude that disequilibria between loci from unlinked regions may be more extensive than is commonly assumed. Our findings also suggest that it is, on average, at least 15 times more likely to not detect significant disequilibrium among unlinked loci when it is really present than to make a false positive inference. Disequilibria between functional loci within or between regions will impact estimates of genetic variance associated with particular functional mutations within a susceptibility gene region.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/42263/1/439-103-3-346_81030346.pd

Traversing the biological complexity in the hierarchy between genome and CAD endpoints in the population at large

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/65382/1/j.1399-0004.1994.tb04196.x.pd

The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome A prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy

AbstractObjectivesOn the basis of quantitative coronary angiography data, the cholesteryl ester transfer protein (CETP) TaqIB gene polymorphism has been postulated to predict the progression of coronary atherosclerosis and response to cholesterol-lowering therapy.BackgroundCholesteryl ester transfer protein mediates the exchange of lipids between anti-atherogenic high-density lipoprotein (HDL) and atherogenic apolipoprotein B containing lipoproteins and therefore plays a key role in human lipid metabolism. Hence, CETP gene polymorphisms may alter susceptibility to atherosclerosis.MethodsTo investigate the significance of the CETP TaqIB gene polymorphism with respect to clinical end points, we used the Cholesterol And Recurrent Events (CARE) cohort. The CARE study was designed to investigate the effect of five years of pravastatin therapy on coronary events.ResultsWe found that the odds ratios for the primary end point were not significantly different from unity for the three genetic subgroups after five years of placebo treatment. Furthermore, pravastatin induced similar changes in total cholesterol, low-density lipoprotein cholesterol, and HDL cholesterol among TaqIB genotypes, and both nonfatal myocardial infarction and deaths from coronary heart disease were reduced to the same extent in all three genotypes.ConclusionsIn the CARE cohort, the CETP TaqIB polymorphism does not predict cardiovascular events or discriminate between those who will or will not benefit from pravastatin treatment

Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy

OBJECTIVE: The purpose of this study was to investigate the association between the Ala227Pro polymorphism in the ADAMTS1 metalloproteinase gene and coronary heart disease and benefit from statin therapy in 2 independent cohorts. METHODS AND RESULTS: The frequency of the ADAMTS1 227Pro minor allele was 0.24 in 2421 male subjects from CARE, a randomized trial of pravastatin versus placebo. In the placebo arm, homozygotes (6.3% of study population) had a significantly increased risk of fatal coronary disease or nonfatal myocardial infarction (D/MI) compared with noncarriers (OR 2.12, 95% CI 1.07 to 4.19, P=0.03), and in the entire study the benefit of pravastatin in reducing the risk of D/MI was greater in these subjects (OR 0.21, 95% CI 0.06 to 0.69) than in heterozygotes (OR 0.74, 95% CI 0.48 to 1.14) or noncarriers (OR 0.99, 95% CI 0.68 to 1.42; P(interaction)=0.044). Results were tested in 1565 male subjects from WOSCOPS, also a randomized trial of pravastatin versus placebo. Similar to the results in CARE, in the placebo arm subjects homozygous for the minor allele were at increased risk of D/MI (OR 1.72, P=0.052) and in the entire study the benefit of pravastatin in reducing D/MI was greater in these subjects (OR 0.24, 95% CI 0.09 to 0.68) than in heterozygotes (OR 0.73, 95% CI 0.48 to 1.11) or noncarriers (OR 0.65, 95% CI 0.20 to 2.09) (P(interaction)=0.029). CONCLUSIONS: In men not on pravastatin, those homozygous for the 227Pro allele of ADAMTS1 have a nearly 2-fold increased risk of coronary heart disease events compared with noncarriers. In this high-risk group, treatment with pravastatin is highly efficacious, reducing the odds of fatal coronary disease or nonfatal MI by approximately 75%, as compared with 25% in noncarriers or heterozygotes